SSA Swiss Advisors’s Gilead Sciences GILD Stock Holding History

SSA Swiss Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-210	Closed	-$25.8K	–	98
2025 Q4	$25.8K	Hold	210	–	–	0.01%	100
2025 Q3	$23.6K	Hold	210	–	–	0.01%	109
2025 Q2	$23.1K	Hold	210	–	–	0.01%	114
2025 Q1	$23.5K	Buy	+210	New	+$21.7K	0.01%	113

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SSA Swiss Advisors's GILD Position: Q1 2026 in Review

SSA Swiss Advisors sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 210 shares — an estimated $25.8K sold.

SSA Swiss Advisors first reported a position in GILD in Q1 2025 and held it in 4 quarters. The position peaked at $25.8K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

SSA Swiss Advisors reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
SSA Swiss Advisors sold 210 Gilead Sciences shares in Q1 2026, an estimated $25.8K.
SSA Swiss Advisors first reported a position in Gilead Sciences in Q1 2025 and held it in 4 quarters.
SSA Swiss Advisors's Gilead Sciences position peaked at $25.8K in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on SSA Swiss Advisors's 13F filing for Q1 2026, filed 21 Jul 2026.